Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Zai Lab Limited ADR’s stock clocked out at $37.33, down -1.79% from its previous closing price of $38.01. In other words, the price has decreased by -$1.79 from its previous closing price. On the day, 0.51 million shares were traded. ZLAB stock price reached its highest trading level at $38.35 during the session, while it also had its lowest trading level at $37.21.
Ratios:
To gain a deeper understanding of ZLAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on March 07, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $55.
On March 03, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $29 to $36.10.
On December 14, 2023, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $47.50.Morgan Stanley initiated its Overweight rating on December 14, 2023, with a $47.50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Amado Rafael sold 3,000 shares for $38.41 per share. The transaction valued at 115,230 led to the insider holds 30,834 shares of the business.
Amado Rafael bought 3,000 shares of ZLAB for $115,230 on Mar 17 ’25. On Mar 05 ’25, another insider, Du Ying, who serves as the Officer of the company, bought 46,389 shares for $35.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 4131535360 and an Enterprise Value of 39535173632. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.21 while its Price-to-Book (P/B) ratio in mrq is 4.78. Its current Enterprise Value per Revenue stands at 99.089 whereas that against EBITDA is -146.285.
Stock Price History:
The Beta on a monthly basis for ZLAB is 1.08, which has changed by 1.3071694 over the last 52 weeks, in comparison to a change of 0.08190584 over the same period for the S&P500. Over the past 52 weeks, ZLAB has reached a high of $39.61, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is 22.76%, while the 200-Day Moving Average is calculated to be 51.12%.
Shares Statistics:
It appears that ZLAB traded 813.57K shares on average per day over the past three months and 682540 shares per day over the past ten days. A total of 109.14M shares are outstanding, with a floating share count of 108.11M. Insiders hold about 0.94% of the company’s shares, while institutions hold 51.11% stake in the company. Shares short for ZLAB as of 1740700800 were 7828888 with a Short Ratio of 9.62, compared to 1738281600 on 7714353. Therefore, it implies a Short% of Shares Outstanding of 7828888 and a Short% of Float of 8.229999000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Zai Lab Limited ADR (ZLAB) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.4 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.32 and -$2.1 for the fiscal current year, implying an average EPS of -$1.61. EPS for the following year is $0.67, with 8.0 analysts recommending between $5.37 and -$0.97.
Revenue Estimates
In the current quarter, 4 analysts expect revenue to total $118.39M. It ranges from a high estimate of $121.92M to a low estimate of $116.4M. As of the current estimate, Zai Lab Limited ADR’s year-ago sales were $87.15MFor the next quarter, 4 analysts are estimating revenue of $130.47M. There is a high estimate of $133.9M for the next quarter, whereas the lowest estimate is $128.5M.
A total of 13 analysts have provided revenue estimates for ZLAB’s current fiscal year. The highest revenue estimate was $582.1M, while the lowest revenue estimate was $551M, resulting in an average revenue estimate of $564.72M. In the same quarter a year ago, actual revenue was $398.99MBased on 13 analysts’ estimates, the company’s revenue will be $833.29M in the next fiscal year. The high estimate is $920M and the low estimate is $715M.
